Good side dishes are always welcomed at a Fourth of July feast in Detroit. And there are times when the dish preparers are ...

In a breakthrough for cardiovascular medicine, US researchers have developed an advanced artificial intelligence (AI) system ...

The biotech sector remains one of the most dynamic areas of the market, driven by clinical breakthroughs, regulatory decisions, and disruptive inn ...

Objectives Infliximab, an anti-TNF agent, is used to treat sarcoidosis that does not respond to corticosteroids or second-line agents. The efficacy of other anti-TNF agents, non-TNF biologics and ...

Michele Morgan Bolton tragically lost her son in a mass shooting near the New York town she'd moved out of to protect her son ...

In other instances, the condition can impact quality of life. But in extreme cases, sarcoidosis can be life-threatening. So, ...

The eye is prone to various forms of afflictions, either as a manifestation of primary ocular disease or part of systemic disease, including the cardiovascular system. A thorough cardiovascular ...

Sarcoidosis is a rare inflammatory condition that develops when groups of cells in your immune system form patches of swollen tissue, called granulomas. These can cluster in the organs of the body, ...

Rationale Health status is impaired in patients with sarcoidosis. There is a paucity of tools that assess health status in sarcoidosis. The objective of this study was to develop and validate the King ...

The Esquimalt teen first embarked on philanthropy a decade ago, writing the book Don't Floss Your Toes at age 5 as a fundraiser for Blau syndrome (early onset sarcoidosis) and juvenile arthritis. Ten ...

Infliximab and efzofitimod may be effective in pulmonary sarcoidosis and tofacitinib and adalimumab in cutaneous sarcoidosis.

The Business Research Company The Business Research Company's Sarcoidosis Drug Global Market Report 2025 – Market Size, Trends, And Global ...